FDA granted orphan drug designation to Sanofi's drug on July 6, 2025.
2 reports, 0 independent
Updated Jul 6
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted orphan drug designation to Sanofi's drug on July 6, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- The FDA recommended advancement for a new drug application submitted by a company.
- Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- Biocon's subsidiary received FDA approval for a drug in the United States on August 18, 2026.
- FDA approval enables commercial opportunity involving CBRE Group.
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet